Intermodality Assessment of Aortic Regurgitation Severity: Insights From Cardiac CT and MRI and Implications for Future Trials

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - 4C Medical; Abbott; Anteris; Alleviant Medical; AriaCV; Boston Scientific Corporation; Edwards Lifesciences; HighLife; Medtronic; JenaValve; Novo Nordisk; Shockwave Medical; Siemens Healthineers; W.L. Gore & Associates; Xylocor
• Grant Support/Research Contract - VDyne; Abbott Northwestern Hospital Foundation; Siemens Healthineers